BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 10753710)

  • 1. High prevalence of hypervariable region 1-specific and -cross-reactive CD4(+) T cells in HCV-infected individuals responsive to IFN-alpha treatment.
    Del Porto P; Puntoriero G; Scottà C; Nicosia A; Piccolella E
    Virology; 2000 Apr; 269(2):313-24. PubMed ID: 10753710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Murine antibodies against E2 and hypervariable region 1 cross-reactively capture hepatitis C virus.
    Esumi M; Ahmed M; Zhou YH; Takahashi H; Shikata T
    Virology; 1998 Nov; 251(1):158-64. PubMed ID: 9813211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of specific CD4+ T cells and antibodies on evolution of hypervariable region 1 during acute HCV infection.
    Scottà C; Garbuglia AR; Ruggeri L; Spada E; Laurenti L; Perrone MP; Girelli G; Mele A; Capobianchi MR; Folgori A; Nicosia A; Del Porto P; Piccolella E;
    J Hepatol; 2008 Feb; 48(2):216-28. PubMed ID: 18180071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Broadly reactive antibodies to hypervariable region 1 in hepatitis C virus-infected patient sera: relation to viral loads and response to interferon.
    Hattori M; Yoshioka K; Aiyama T; Iwata K; Terazawa Y; Ishigami M; Yano M; Kakumu S
    Hepatology; 1998 Jun; 27(6):1703-10. PubMed ID: 9620346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term follow-up after successful interferon therapy of acute hepatitis C.
    Wiegand J; Jäckel E; Cornberg M; Hinrichsen H; Dietrich M; Kroeger J; Fritsch WP; Kubitschke A; Aslan N; Tillmann HL; Manns MP; Wedemeyer H
    Hepatology; 2004 Jul; 40(1):98-107. PubMed ID: 15239091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody-selected mimics of hepatitis C virus hypervariable region 1 activate both primary and memory Th lymphocytes.
    Frasca L; Scottà C; Del Porto P; Nicosia A; Pasquazzi C; Versace I; Masci AM; Racioppi L; Piccolella E
    Hepatology; 2003 Sep; 38(3):653-63. PubMed ID: 12939592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Virus-specific T-cell responses associated with hepatitis C virus (HCV) persistence in the liver after apparent recovery from HCV infection.
    Quiroga JA; Llorente S; Castillo I; Rodríguez-Iñigo E; López-Alcorocho JM; Pardo M; Carreño V
    J Med Virol; 2006 Sep; 78(9):1190-7. PubMed ID: 16847959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypervariable region 1 variant acting as TCR antagonist affects hepatitis C virus-specific CD4+ T cell repertoire by favoring CD95-mediated apoptosis.
    Scottà C; Tuosto L; Masci AM; Racioppi L; Piccolella E; Frasca L
    J Leukoc Biol; 2005 Aug; 78(2):372-82. PubMed ID: 15923217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T cell recognition of hypervariable region-1 from hepatitis C virus envelope protein with multiple class II MHC molecules in mice and humans: preferential help for induction of antibodies to the hypervariable region.
    Shirai M; Arichi T; Chen M; Masaki T; Nishioka M; Ikeda K; Takahashi H; Enomoto N; Saito T; Major ME; Nakazawa T; Akatsuka T; Feinstone SM; Berzofsky JA
    J Immunol; 1999 Jan; 162(1):568-76. PubMed ID: 9886434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies in human sera specific to hypervariable region 1 of hepatitis C virus can block viral attachment.
    Zibert A; Schreier E; Roggendorf M
    Virology; 1995 Apr; 208(2):653-61. PubMed ID: 7538251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mimotopes of the hepatitis C virus hypervariable region 1, but not the natural sequences, induce cross-reactive antibody response by genetic immunization.
    Zucchelli S; Roccasecca R; Meola A; Ercole BB; Tafi R; Dubuisson J; Galfré G; Cortese R; Nicosia A
    Hepatology; 2001 Mar; 33(3):692-703. PubMed ID: 11230750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A hyperimmune serum against a synthetic peptide corresponding to the hypervariable region 1 of hepatitis C virus can prevent viral infection in cell cultures.
    Shimizu YK; Igarashi H; Kiyohara T; Cabezon T; Farci P; Purcell RH; Yoshikura H
    Virology; 1996 Sep; 223(2):409-12. PubMed ID: 8806581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody responses to hepatitis C virus hypervariable region 1: evidence for cross-reactivity and immune-mediated sequence variation.
    Mondelli MU; Cerino A; Lisa A; Brambilla S; Segagni L; Cividini A; Bissolati M; Missale G; Bellati G; Meola A; Bruniercole B; Nicosia A; Galfrè G; Silini E
    Hepatology; 1999 Aug; 30(2):537-45. PubMed ID: 10421665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypervariable region 1 variants act as TCR antagonists for hepatitis C virus-specific CD4+ T cells.
    Frasca L; Del Porto P; Tuosto L; Marinari B; Scottà C; Carbonari M; Nicosia A; Piccolella E
    J Immunol; 1999 Jul; 163(2):650-8. PubMed ID: 10395654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Broadly cross-reactive, high-affinity antibody to hypervariable region 1 of the hepatitis C virus in rabbits.
    Shang D; Zhai W; Allain JP
    Virology; 1999 Jun; 258(2):396-405. PubMed ID: 10366577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conservation of the conformation and positive charges of hepatitis C virus E2 envelope glycoprotein hypervariable region 1 points to a role in cell attachment.
    Penin F; Combet C; Germanidis G; Frainais PO; Deléage G; Pawlotsky JM
    J Virol; 2001 Jun; 75(12):5703-10. PubMed ID: 11356980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early antibody response against hypervariable region 1 is associated with acute self-limiting infections of hepatitis C virus.
    Zibert A; Meisel H; Kraas W; Schulz A; Jung G; Roggendorf M
    Hepatology; 1997 May; 25(5):1245-9. PubMed ID: 9141445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Memory T-cell-mediated immune responses specific to an alternative core protein in hepatitis C virus infection.
    Bain C; Parroche P; Lavergne JP; Duverger B; Vieux C; Dubois V; Komurian-Pradel F; Trépo C; Gebuhrer L; Paranhos-Baccala G; Penin F; Inchauspé G
    J Virol; 2004 Oct; 78(19):10460-9. PubMed ID: 15367612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Towards a solution for hepatitis C virus hypervariability: mimotopes of the hypervariable region 1 can induce antibodies cross-reacting with a large number of viral variants.
    Puntoriero G; Meola A; Lahm A; Zucchelli S; Ercole BB; Tafi R; Pezzanera M; Mondelli MU; Cortese R; Tramontano A; Galfre' G; Nicosia A
    EMBO J; 1998 Jul; 17(13):3521-33. PubMed ID: 9649423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Broadly cross-reactive mimotope of hypervariable region 1 of hepatitis C virus derived from DNA shuffling and screened by phage display library.
    Zhang XX; Deng Q; Zhang SY; Liu J; Cai Q; Lu ZM; Wang Y
    J Med Virol; 2003 Dec; 71(4):511-7. PubMed ID: 14556263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.